Stock Price
4.07
Daily Change
-1.06 -20.66%
Monthly
3.56%
Yearly
126.11%
Q2 Forecast
5.00

Acasti Pharma reported $66.58M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acasti Pharma USD 66.58M 3.22M Sep/2025
Addus HomeCare USD 1.44B 14.37M Dec/2025
Amarin USD 670.78M 10.96M Dec/2025
Cassava Sciences USD 118.35M 11.38M Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Option Care Health USD 3.46B 24.08M Dec/2025
Organigram Holdings CAD 530.67M 31.54M Dec/2025
Tilray USD 2.1B 15.95M Sep/2025